KING OF PRUSSIA, Pa., Sept. 28, 2017 /PRNewswire/ -- The Great Lakes Hemophilia Foundation (GLHF) headquartered in Milwaukee, Wis., the New York City Hemophilia Chapter (NYCHC) and the Ohio Bleeding Disorders Council (OBDC) in Columbus take on complex legislative and public policy issues to ensur...Read More
(TheNewswire) Vancouver, BC / TheNewswire / September 28, 2017 - Comstock Metals Ltd. (TSX-V: CSL) ("Comstock" or the "Company") is pleased to report partial results from the summer diamond drilling program at its 100% owned Preview SW gold project located 40 km northeast of La Ronge, Saskatche...Read More
TOKYO, Sept. 28, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved AFSTYLA (R) (hereafter AFSTYLA) [lonoctocog alfa] a recombinant single-chain coagulation factor VIII (rVIII-SingleChain) in...Read More
UNIVERSITY PARK, Pa., Sept. 19, 2017 /PRNewswire/ -- Penn State today announced that CSL Behring, a global specialty biotherapeutics leader, has committed $4.92 million to Penn State over the next six years to create the multidisciplinary Center of Excellence in Biotechnology, and to revitalize...Read More
VANCOUVER, British Columbia, Sept.15, 2017(GLOBE NEWSWIRE) -- Comstock Metals Ltd. (TSX-V:CSL) ("Comstock" or the "Company") is pleased to announce that it has commenced a core drilling program on its 100% owned QV gold project located in the heart of the prolific White Gold district of the Yuko...Read More
EDINBURGH, United Kingdom, Sept. 14, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that its "Join Together" campaign at the 2017 European Society for Immunodeficiencies (ESID) meeting has resulted in a ?,?15,000 donation to IPOPI, the International Patient Organis...Read More
KING OF PRUSSIA, Pa., Sept. 14, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the U.S. Food and Drug Administration (FDA) has approved Privigen (R) [Immune Globulin Intravenous (Human), 10% Liquid] for the treatment of adults with chronic inflammatory demyeli...Read More
VANCOUVER, British Columbia, Sept.12, 2017(GLOBE NEWSWIRE) -- Comstock Metals Ltd. (TSX-V:CSL) ("Comstock" or the "Company") announced today that it has been advised that the offer made by SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irre...Read More
Canadian parents who are educated about immunizing their infants against influenza with an adjuvanted trivalent influenza vaccine (aTIV) see it as a wise, effective, and safe choice. But public-funding status can greatly influence their opinions and intentions to actually immunize children wi...Read More
Annual influenza-related pediatric hospitalizations in Canada have ranged from about 700 to 1,500 during the last five influenza seasons, and a total of nearly 50 influenza-related paediatric deaths have occurred across that time span, according to the Canadian government.1 One potential solu...Read More
VANCOUVER, British Columbia, Sept.07, 2017(GLOBE NEWSWIRE) -- Comstock Metals Ltd. (TSX-V:CSL) ("Comstock" or the "Company") announced today that it has been advised that the deadline for Select Sands Corp. to respond to the previously disclosed offer made by SJ Strategic Investments, LLC, Grace...Read More
VANCOUVER, British Columbia, Sept.06, 2017(GLOBE NEWSWIRE) -- Comstock Metals Ltd. (TSX-V:CSL) ("Comstock" or the "Company") announced today that it has been advised that the deadline for Select Sands Corp. to respond to the offer made by SJ Strategic Investments, LLC, Gracetree Investments, LLC...Read More
VANCOUVER, BC--(Marketwired - September 05, 2017) - Comstock Metals Ltd. (TSX VENTURE: CSL) ("Comstock" or the "Company") announced today that it is reviewing the offer made by SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Eq...Read More
VANCOUVER, British Columbia, Sept. 1, 2017 /PRNewswire/ -- SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly (collectively the "Syndicate"), announced that they have filed an early warning report in...Read More
VANCOUVER, Sept. 1, 2017 /CNW/ - SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly (collectively the "Syndicate"), announced that they have filed an early warning report in respect of an offer (the "...Read More
KING OF PRUSSIA, Pa., Aug. 28, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that it has agreed to acquire Calimmune, Inc., a biotechnology company focused on the development of ex vivo hematopoietic stem cell (HSC) gene therapy with R&D facilities in Pasadena, Ca...Read More
VANCOUVER, BC--(Marketwired - August 24, 2017) - Comstock Metals Ltd. (TSX VENTURE: CSL) ("Comstock" or the "Company") is pleased to announce that it has completed the previously announced summer exploration program at its 100% owned Preview SW gold project, located 40 km northeast of La Ronge,...Read More
OTTAWA, Canada, Aug. 9, 2017 /CNW/ -- CSL Behring is pleased to announce that on March 31st, 2017 Berinert (C1 Esterase Inhibitor, Human) was approved by Heath Canada for Pediatric Hereditary Angioedema (HAE). "HAE is an unpredictable and life threatening disease with few treatment options appr...Read More
KING OF PRUSSIA, Pa., July 25, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]) is now available in the United States. The U.S. Food and Drug Administration (FDA) approved HAEGARDA on June 22, 2017...Read More
KING OF PRUSSIA, Pa., July 21, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted the Company seven years of orphan-drug exclusivity for HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]), the first and...Read More